eIF5B Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF5B monoclonal antibodies for investigating eIF5B's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF5B, or eukaryotic translation initiation factor 5B, plays a crucial role in the initiation of protein synthesis by facilitating the joining of the ribosomal subunits and the mRNA. eIF5B is essential for the proper translation of mRNA into proteins, which is vital for numerous cellular functions and overall cellular health. Research has shown that eIF5B activity is closely linked to cell growth, proliferation, and development. Understanding eIF5B function has significant implications for cancer research and therapeutic development. Dysregulation of eIF5B has been implicated in various diseases, highlighting its importance as a research target. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enabling diverse experimental approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of eIF5B's role in cellular processes and disease mechanisms.